Niraparib Combo Boosts rPFS in Metastatic HRR-Altered CSPC

Combining niraparib (Zejula) with abiraterone acetate (Zytiga) and prednisone (AAP) significantly prolonged radiographic progression-free survival (rPFS) vs placebo plus AAP among patients with metastatic castration-sensitive prostate cancer…